DaShenLin Pharmaceutical Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Guoqiang Ke
Chief executive officer
CN¥2.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | no data |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Take Care Before Diving Into The Deep End On DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233)
Sep 30
DaShenLin Pharmaceutical Group Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sep 03DaShenLin Pharmaceutical Group (SHSE:603233) May Have Issues Allocating Its Capital
Aug 20Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%
Jun 17Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?
Jun 09Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?
May 21Some May Be Optimistic About DaShenLin Pharmaceutical Group's (SHSE:603233) Earnings
May 06Investors Could Be Concerned With DaShenLin Pharmaceutical Group's (SHSE:603233) Returns On Capital
Apr 09Lacklustre Performance Is Driving DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Low P/E
Mar 17CEO
Guoqiang Ke (42 yo)
5.8yrs
Tenure
CN¥2,308,800
Compensation
Mr. Guoqiang Ke is General Manager of DaShenLin Pharmaceutical Group Co., Ltd. from February 28, 2019 and serves as DIrector since February 03, 2023. He was Deputy General Manager of DaShenLin Pharmaceutic...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 1.8yrs | CN¥2.31m | 0.025% CN¥ 4.6m | |
| Deputy GM & Director | 1.8yrs | CN¥2.05m | 0.024% CN¥ 4.4m | |
| Chairman of Supervisory Board & Deputy Director of Human Resources Department - Guangdong Province | no data | no data | 0.012% CN¥ 2.2m | |
| Chairman of the Board | no data | CN¥2.49m | 21.3% CN¥ 4.0b | |
| Independent Director | no data | CN¥73.40k | no data | |
| Independent Director | no data | CN¥80.00k | no data | |
| Director | no data | no data | no data | |
| Independent Director | no data | CN¥80.00k | no data | |
| Staff Supervisor | no data | no data | 0.00055% CN¥ 103.0k | |
| Supervisor | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
54yo
Average Age
Experienced Board: 603233's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 00:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DaShenLin Pharmaceutical Group Co., Ltd. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shaoling Wang | Chasing Securities |
| Qianyi Li | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |